Frequencies of CD19+, MZ, FO, and eGFP+ B cells in the spleen of irf4floxedCD20-TAM-Cre mice at days 11–14 after TAM administration
| Genotype | % CD19+ cells | Among CD19+ cells | % eGFP+CD19+ cells | % eGFP+ B cells | ||
| % MZ | % FO | Among MZ | Among FO | |||
| irf4+/+CD20-TAM-Cre (n = 4) | 45.6 ± 5.2 | 8.5 ± 1.2 | 79.8 ± 3.0 | 1.7 ± 0.5 | - | - |
| irf4fl/+CD20-TAM-Cre (n = 8) | 39.3 ± 7.2 | 10.2 ± 1.6 | 75.4 ± 4.2 | 49.9 ± 6.6 | 56.5 ± 8.0 | 55.6 ± 4.1 |
| irf4fl/flCD20-TAM-Cre (n = 6) | 42.1 ± 5.5 | 8.4 ± 1.2 | 74.9 ± 2.6 | 54.1 ± 12.4 | 60.5 ± 10.2 | 58.2 ± 10.1 |
| Genotype | % CD19+ cells | Among CD19+ cells | % eGFP+CD19+ cells | % eGFP+ B cells | ||
| % MZ | % FO | Among MZ | Among FO | |||
| irf4+/+CD20-TAM-Cre (n = 4) | 45.6 ± 5.2 | 8.5 ± 1.2 | 79.8 ± 3.0 | 1.7 ± 0.5 | - | - |
| irf4fl/+CD20-TAM-Cre (n = 8) | 39.3 ± 7.2 | 10.2 ± 1.6 | 75.4 ± 4.2 | 49.9 ± 6.6 | 56.5 ± 8.0 | 55.6 ± 4.1 |
| irf4fl/flCD20-TAM-Cre (n = 6) | 42.1 ± 5.5 | 8.4 ± 1.2 | 74.9 ± 2.6 | 54.1 ± 12.4 | 60.5 ± 10.2 | 58.2 ± 10.1 |